Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
Barmawi Hisyam Barmawi Hisyam
Unknown Affiliation
Immunology & microbiology Neuroscience

Published : 8 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 8 Documents
Search

 1 
The benefits of steroid as therapy for tuberculous effusion Barmawi Hisyam, Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 33, No 03 (2001)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (80.824 KB)

Abstract

Tuberculous effusion is a complication of pulmonary or extra pulmonary tuberculosis. The specific diagnosis is made by the finding of mycobacterium in the effusion and pleural tissue. Therapy of tuberculous effusion is mainly reducing symptoms, prevent progressivity and fibrothorax. Common complications of tuberculous effusion are pleural fibrosis, thickening and calcification of pleura. To prevent those, corticosteroid is often needed as additional therapy, besides anti tuberculous drugs. There has been controversy about the benefits of steroid as therapy for tuberculous effusion.Keywords : pulmonary tuberculosis, extrapulmonary tuberculosis, tuberculous effusion, corticosteroids, anti tuberculous drugs.,
The pattern of bacterias causes pneumonia on Sardjito General Hospital January 1, 1990 - December 31, 1994 Barmawi Hisyam, Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 30, No 03 (1998)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (80.671 KB)

Abstract

Pneumonia has high morbidity and mortality. The clinical classification of Community Acquired Pneumonia (CAP) and Hospital Acquired Pneumonia (HAP) and the empirical treatment have beneficial means to prevent the severity of the disease. A retrospective study had been conducted, by evaluating the medical record of the patients hospitalised in the Department of Internal Medicine Dr. Sardjito General Hospital, January 1, 1990 -December 31, 1994. There were 221 cases of pneumonia, the major frequency on range 45-64 years old: 84 (38,01%), men/women ratio: 1.5 : 1. The CAP was more than HAP: 200 (90,50%) vs 21 (9,50%). Bacterias causes CAP: Streptococcus alpha 36 (29,75%), Staphylococcus aureus 28 (23,14%) and Klebsiella pneumonia 27 (22,31%). While the bacteria cause of typical HAP: Klebsiella pneumoniae 1 (100%), mixed bacterias causes HAP: Streptococcus alpha 3 (33,33%), Staphylococcus aureus 3 (33,33%) and Klebsiella pneumoniae 2 (22,22%). There were no difference the pattern of bacterias causes CAP or HAP.Key Words : the pattern of bacteria - typical bacteria - mixed bacterias - CAP - HAP
Efficacy of corticosteroid in pulmonary and extrapulmonary tuberculosis Barmawi Hisyam, Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 33, No 02 (2001)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (129.478 KB)

Abstract

Tuberculosis is one of major health problems all over the world. The epidemiologic data shows an increase in its morbidity and mortality. Infection of tuberculosis involves almost every organ of the body, ie. respiratory organ, known as pulmonary tuberculosis and other organs, known as extrapulmonary tuberculosis. The World Health Organization (WHO) has recently published programme guidlines for the treatment of tuberculosis. In certain cases, especially extrapulmonary tuberculosis, a combination of anti-tuberculous drugs and corticosteroid is assumed to be useful.Key words : pulmonary tuberculosis - extrapulmonary tuberculosis - anti tuberculous drug - corticosteroid
Hypophosphatemia in lung disease. Is there any cause and effect relationship ? Barmawi Hisyam, Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 27, No 04 (1995)
Publisher : Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (219.91 KB)

Abstract

Many reports showed that hypophosphatemia is prevalent in patients of lung disease with respiratory failure. Correction for hypophosphatemia may improve respiratory capacity, hence, morbidity and mortality. Serum phosphate levels may reflect intracelluler phosphate pool. A decrease in intracellular phosphate may implicate muscular adenosine tri-phosphate (ATP) and red blood cell 2,3 di-phosphoglycerate (DPG) synthesis. Reduction in respiratory muscle ATP will reduce respiratory since ATP is the the source of energy for muscle contraction. Reduction in red blood cel 2,3 DPG will shift hemoglobin dissociation curve to the left that lead to the disturbance of oxygen extraction by the cells. Hypoxia may be resulted from those processes, therefore, recoils the poor capacity of the respiratory muscle. Underlying primary lung diseases may partly play a role in the genesis of hypophosphatemia. Drugs often used for the disease, such as corticosteroids, xathine identification and treatment of hypophosphatemia in lung disease with or without respiratory failure in order to improve morbidity and mortality of the patients.Keywords : hypophosphatemia - adenosine tri-phosphate - 2,3 di- phosphoglycerate - hypoxia – respiratory- failure 
Efficacy of corticosteroid in pulmonary and extrapulmonary tuberculosis Barmawi Hisyam Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 33, No 02 (2001)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (129.478 KB)

Abstract

Tuberculosis is one of major health problems all over the world. The epidemiologic data shows an increase in its morbidity and mortality. Infection of tuberculosis involves almost every organ of the body, ie. respiratory organ, known as pulmonary tuberculosis and other organs, known as extrapulmonary tuberculosis. The World Health Organization (WHO) has recently published programme guidlines for the treatment of tuberculosis. In certain cases, especially extrapulmonary tuberculosis, a combination of anti-tuberculous drugs and corticosteroid is assumed to be useful.Key words : pulmonary tuberculosis - extrapulmonary tuberculosis - anti tuberculous drug - corticosteroid
The benefits of steroid as therapy for tuberculous effusion Barmawi Hisyam Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 33, No 03 (2001)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (80.824 KB)

Abstract

Tuberculous effusion is a complication of pulmonary or extra pulmonary tuberculosis. The specific diagnosis is made by the finding of mycobacterium in the effusion and pleural tissue. Therapy of tuberculous effusion is mainly reducing symptoms, prevent progressivity and fibrothorax. Common complications of tuberculous effusion are pleural fibrosis, thickening and calcification of pleura. To prevent those, corticosteroid is often needed as additional therapy, besides anti tuberculous drugs. There has been controversy about the benefits of steroid as therapy for tuberculous effusion.Keywords : pulmonary tuberculosis, extrapulmonary tuberculosis, tuberculous effusion, corticosteroids, anti tuberculous drugs.,
The pattern of bacterias causes pneumonia on Sardjito General Hospital January 1, 1990 - December 31, 1994 Barmawi Hisyam Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 30, No 03 (1998)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (80.671 KB)

Abstract

Pneumonia has high morbidity and mortality. The clinical classification of Community Acquired Pneumonia (CAP) and Hospital Acquired Pneumonia (HAP) and the empirical treatment have beneficial means to prevent the severity of the disease. A retrospective study had been conducted, by evaluating the medical record of the patients hospitalised in the Department of Internal Medicine Dr. Sardjito General Hospital, January 1, 1990 -December 31, 1994. There were 221 cases of pneumonia, the major frequency on range 45-64 years old: 84 (38,01%), men/women ratio: 1.5 : 1. The CAP was more than HAP: 200 (90,50%) vs 21 (9,50%). Bacterias causes CAP: Streptococcus alpha 36 (29,75%), Staphylococcus aureus 28 (23,14%) and Klebsiella pneumonia 27 (22,31%). While the bacteria cause of typical HAP: Klebsiella pneumoniae 1 (100%), mixed bacterias causes HAP: Streptococcus alpha 3 (33,33%), Staphylococcus aureus 3 (33,33%) and Klebsiella pneumoniae 2 (22,22%). There were no difference the pattern of bacterias causes CAP or HAP.Key Words : the pattern of bacteria - typical bacteria - mixed bacterias - CAP - HAP
Hypophosphatemia in lung disease. Is there any cause and effect relationship ? Barmawi Hisyam Barmawi Hisyam
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 27, No 04 (1995)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (219.91 KB)

Abstract

Many reports showed that hypophosphatemia is prevalent in patients of lung disease with respiratory failure. Correction for hypophosphatemia may improve respiratory capacity, hence, morbidity and mortality. Serum phosphate levels may reflect intracelluler phosphate pool. A decrease in intracellular phosphate may implicate muscular adenosine tri-phosphate (ATP) and red blood cell 2,3 di-phosphoglycerate (DPG) synthesis. Reduction in respiratory muscle ATP will reduce respiratory since ATP is the the source of energy for muscle contraction. Reduction in red blood cel 2,3 DPG will shift hemoglobin dissociation curve to the left that lead to the disturbance of oxygen extraction by the cells. Hypoxia may be resulted from those processes, therefore, recoils the poor capacity of the respiratory muscle. Underlying primary lung diseases may partly play a role in the genesis of hypophosphatemia. Drugs often used for the disease, such as corticosteroids, xathine identification and treatment of hypophosphatemia in lung disease with or without respiratory failure in order to improve morbidity and mortality of the patients.Keywords : hypophosphatemia - adenosine tri-phosphate - 2,3 di- phosphoglycerate - hypoxia – respiratory- failure 
Co-Authors